Search

Your search keyword '"Chung, H.T."' showing total 203 results

Search Constraints

Start Over You searched for: Author "Chung, H.T." Remove constraint Author: "Chung, H.T."
203 results on '"Chung, H.T."'

Search Results

2. Brachytherapy for high grade prostate cancer induces distinct changes in circulating CD4 and CD8 T cells – Implications for systemic control

5. Dosimetric Predictors of Toxicities and Quality of Life Following Two-Fraction Stereotactic Body Radiotherapy for Prostate Cancer

6. Dosimetric Parameters Predictive of Treatment-Related Toxicity in High Dose-Rate Brachytherapy as Monotherapy for Prostate Cancer

11. Recursive Partitioning Model to Identify Early Progression in Patients with Extracranial Oligometastatic Colorectal Cancer Treated with Stereotactic Body Radiotherapy

12. Development of a Support Vector Machine-Based Tool for Survival Prediction after Stereotactic Body Radiotherapy for Liver Metastases Using Multi-Institutional Data

13. Five-Fraction Stereotactic Ablative Radiotherapy to the Pelvis and Prostate with Focal Intra-Prostatic Boost: Outcomes of the 5STAR Trial

14. Salvage Prostate Brachytherapy in Radiorecurrent Prostate Cancer: An International Delphi Consensus Study

17. Biochemical Failure and Toxicity of Magnetic Resonance Imaging Dose Painting to Dominant Intraprostatic Lesion in Prostate High Dose Rate Brachytherapy

18. Elective Pelvic Nodal Irradiation With A Simultaneous Hypofractionated Integrated Prostate Boost for Localized High Risk Prostate Cancer: Long Term Results From a Prospective Clinical Trial

19. Dosimetric Predictors of Toxicity and Quality of Life Following Single Fraction High Dose-Rate Prostate Brachytherapy

20. Elective Nodal Ultra Hypofractionated Radiation for Prostate Cancer: Safety and Efficacy From Four Prospective Clinical Trials

26. Stereotactic Ablative Radiotherapy (SABR) in Oligometastatic and Oligoprogressive Gynecologic Cancers: Clinical Outcomes of a Single Institution Analysis

33. Accelerating Prostate Stereotactic Ablative Body Radiotherapy (SABR): Efficacy and Toxicity of a Randomized Phase II Study of 11 Versus 29 Days Overall Treatment Time (PATRIOT Study; ClinicalTrials.gov NCT01423474)

36. Comprehensive Stereotactic Radiotherapy for Oligometastatic Prostate Cancer (CROP)

39. PSA Bounce after Stereotactic Body Radiation Therapy for Prostate Cancer: Pooled Analysis from 4 SBRT Trials Evaluating Different Time-Dose-Fraction Schedules

44. Stereotactic Body Radiation Therapy for Metastatic Colorectal Cancer: Comprehensive Review from a Large Academic Institution

45. Abstract PCCLB-52

46. Stereotactic Body Radiotherapy (SBRT) Boost to Mimic High-Dose Rate (HDR) Brachytherapy Boost for Intermediate Risk Prostate Cancer: A Phase 1 Study

Catalog

Books, media, physical & digital resources